# SGLT2 inhibitor

Glossary term · id `cardio:term-sglt2-inhibitor` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also written: SGLT2 inhibitors; SGLT-2 inhibitors; sodium-glucose transporter 2 inhibitors

A class of medicines that lower blood sugar by stopping the kidney from taking glucose back into the blood, and are used to treat type 2 diabetes. Some are also approved to lower the risk of hospital stays for heart failure in adults with heart failure, and the risk of kidney disease getting worse in adults who have chronic kidney disease. [1, 2]

## See also

- SGLT2 inhibitors (drug class) (`cardio:sglt2-inhibitors`)

## Sources

1. MeSH scope note for descriptor D000077203 (Sodium-Glucose Transporter 2 Inhibitors) (Dataset, U.S. National Library of Medicine) <https://id.nlm.nih.gov/mesh/M000639744>. Locator: scopeNote.@value. Retrieved 2026-10-25.
2. openFDA drug label record for FARXIGA (dapagliflozin tablets): indications and usage (Regulator, U.S. Food and Drug Administration (openFDA)) <https://api.fda.gov/drug/label.json?search=openfda.brand_name:%22FARXIGA%22&limit=1>. Locator: results\[0\].indications\_and\_usage\[0\]. Retrieved 2026-10-25.

## Provenance

Content hash: 5195d3f8ebe65ad605d17281a95e046cb80890e32e3929bcaaf12681ff604041
Last substantive edit: 2026-10-25
Evidence last checked: 2026-10-25
